These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8138883)

  • 21. Convergent validity of alternative MMPI-2 personality disorder scales.
    Hicklin J; Widiger TA
    J Pers Assess; 2000 Dec; 75(3):502-18. PubMed ID: 11117160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADHD in adult psychiatry. Minimum rates and clinical presentation in general psychiatry outpatients.
    Nylander L; Holmqvist M; Gustafson L; Gillberg C
    Nord J Psychiatry; 2009; 63(1):64-71. PubMed ID: 18991159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the correlational structures and elevation patterns of the MMPI-2 restructured clinical (RC) and clinical scales.
    Wallace A; Liljequist L
    Assessment; 2005 Sep; 12(3):290-4. PubMed ID: 16123249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MMPI as a predictor of early termination from polydrug abuse treatment.
    Keegan JF; Lachar D
    J Pers Assess; 1979 Aug; 43(4):379-84. PubMed ID: 480112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MMPI predictors of mania among psychiatric inpatients.
    Post RD; Clopton JR; Keefer G; Rosenberg D; Blyth LS; Stein M
    J Pers Assess; 1986; 50(2):248-56. PubMed ID: 3761127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social phobia in an outpatient alcohol and drug treatment sample.
    Adamson SJ; Sellman JD; Robertson PJ
    Aust N Z J Psychiatry; 2008 Feb; 42(2):134-40. PubMed ID: 18197508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders.
    Zimmerman M; Sheeran T; Chelminski I; Young D
    J Subst Abuse Treat; 2004 Apr; 26(3):181-8. PubMed ID: 15063911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of three abbreviated MMPIs for psychiatric patients and normals.
    Newmark CS; Owen M; Newmark L; Faschingbauer TR
    J Pers Assess; 1975 Jun; 39(3):261-70. PubMed ID: 1185495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the usefulness of the MMPI-2 F(p) scale.
    Archer RP; Handel RW; Greene RL; Baer RA; Elkins DE
    J Pers Assess; 2001 Apr; 76(2):282-95. PubMed ID: 11393461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The predictive capacity of the MMPI-2 and PAI validity scales and indexes to detect coached and uncoached feigning.
    Bagby RM; Nicholson RA; Bacchiochi JR; Ryder AG; Bury AS
    J Pers Assess; 2002 Feb; 78(1):69-86. PubMed ID: 11936213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MMPI measures as signs of predisposition to mental disorder among adoptees at high risk for schizophrenia.
    Siira V; Wahlberg KE; Miettunen J; Läksy K; Tienari P
    Psychiatry Res; 2008 Apr; 158(3):278-86. PubMed ID: 18272233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A trial for the complex risk assessment of repeated suicide predictors in patients after suicidal poisoning attempts, hospitalized in the Department of Clinical Toxicology CM UJ in Krakow. II. Clinical predictors].
    Pach J; Polewka A; Zieba A; Kroch S; Chrostek Maj J; Mikołaszek-Boba M; Datka W; Rachel W
    Przegl Lek; 2001; 58(4):330-4. PubMed ID: 11450362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial bias in personality assessment: using the MMPI-2 to predict psychiatric diagnoses of African American and Caucasian chemical dependency inpatients.
    Monnot MJ; Quirk SW; Hoerger M; Brewer L
    Psychol Assess; 2009 Jun; 21(2):137-51. PubMed ID: 19485669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MMPI-2 critical item norms in chemically dependent inpatients.
    Ladd JS
    J Clin Psychol; 1996 May; 52(3):367-72. PubMed ID: 8835700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of the Malingering Discriminant Function Index for the MMPI-2.
    Bacchiochi JR; Bagby RM
    J Pers Assess; 2006 Aug; 87(1):51-61. PubMed ID: 16856786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two- and three-point classification of MMPI profiles in which scales 2, 7, and 8 are the highest elevations.
    Kelley CK; King GD
    J Pers Assess; 1980 Feb; 44(1):25-33. PubMed ID: 7359303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates of apparently abnormal MMPI-2 profiles in the normal population.
    Odland AP; Martin P; Perle J; Simco ER; Mittenberg W
    Clin Neuropsychol; 2011 Oct; 25(7):1134-44. PubMed ID: 21861780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.